Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer

Gynecologic Oncology

Volumn 109, Issue 1, 2008, Pages 115-121

  Stammer, Karen ^a   Edassery, Seby L ^a   Barua, Animesh ^a   Bitterman, Pincas ^a   Bahr, Janice M ^b   Hales, Dale Buchanan ^c   Luborsky, Judith L ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Animal model; Chickens; Ovarian cancer; Selenium Binding Protein 1

Indexed keywords

MESSENGER RNA; SELENIUM BINDING PROTEIN; SELENIUM BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; HEN; HISTOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; CHICKENS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; OVARY; RNA, MESSENGER; SELENIUM-BINDING PROTEINS;

EID: 40949123365     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.12.030     Document Type: Article

References (46)

1. Lanzillotti J.S., and Tang A.M. Micronutrients and HIV disease: a review pre- and post-HAART. Nutr Clin Care 8 (2005) 16-23
2. Ryan-Harshman M., and Aldoori W. The relevance of selenium to immunity, cancer, and infectious/inflammatory diseases. Can J Diet Pract Res 66 (2005) 98-102
3. Rayman M.P. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc 64 (2005) 527-542
4. Beckett G.J., and Arthur J.R. Selenium and endocrine systems. J Endocrinol 184 (2005) 455-465
5. Schweizer U., and Schomburg L. New insights into the physiological actions of selenoproteins from genetically modified mice. IUBMB Life 57 (2005) 737-744
6. Letavayova L., Vlckova V., and Brozmanova J. Selenium: from cancer prevention to DNA damage. Toxicology 227 (2006) 1-14
7. Dennert G., and Horneber M. Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients. Cochrane Database Syst Rev 3 (2006) CD005037
8. Aboul-Fadl T. Selenium derivatives as cancer preventive agents. Curr Med Chem Anti-canc Agents 5 (2005) 637-652
9. Klein E.A. Selenium: epidemiology and basic science. J Urol 171 (2004) S50-S53 discussion S53
10. Klein E.A. Selenium and vitamin E cancer prevention trial. Ann NY Acad Sci 1031 (2004) 234-241
11. Lee S.O., Yeon Chun J., Nadiminty N., Trump D.L., Ip C., Dong Y., et al. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Prostate 66 (2006) 1070-1075
12. Dong Y., Zhang H., Gao A.C., Marshall J.R., and Ip C. Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers. Mol Cancer Ther 4 (2005) 1047-1055
13. Etminan M., FitzGerald J.M., Gleave M., and Chambers K. Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control 16 (2005) 1125-1131
14. Behne D., and Kyriakopoulos A. Mammalian selenium-containing proteins. Annu. Rev. Nutr. 21 (2001) 453-473
15. Bansal M.P., Mukhopadhyay T., Scott J., Cook R.G., Mukhopadhyay R., and Medina D. DNA sequencing of a mouse liver protein that binds selenium: implications for selenium's mechanism of action in cancer prevention. Carcinogenesis 11 (1990) 2071-2073
16. Chang P.W., Tsui S.K., Liew C., Lee C.C., Waye M.M., and Fung K.P. Isolation, characterization, and chromosomal mapping of a novel cDNA clone encoding human selenium binding protein. J Cell Biochem 64 (1997) 217-224
17. Huang K.C., Park D.C., Ng S.K., Lee J.Y., Ni X., Ng W.C., et al. Selenium binding protein 1 in ovarian cancer. Int J Cancer 118 (2006) 2433-2440
18. Kim H., Kang H.J., You K.T., Kim S.H., Lee K.Y., Kim T.I., et al. Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics 6 (2006) 3466-3476
19. Yang M., and Sytkowski A.J. Differential expression and androgen regulation of the human selenium-binding protein gene hSP56 in prostate cancer cells. Cancer Res 58 (1998) 3150-3153
20. Chen G., Wang H., Miller C.T., Thomas D.G., Gharib T.G., Misek D.E., et al. Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas. J Pathol 202 (2004) 321-329
21. He Q.Y., Cheung Y.H., Leung S.Y., Yuen S.T., Chu K.M., and Chiu J.F. Diverse proteomic alterations in gastric adenocarcinoma. Proteomics 4 (2004) 3276-3287
22. Brown L.M., Helmke S.M., Hunsucker S.W., Netea-Maier R.T., Chiang S.A., Heinz D.E., et al. Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue. Mol Carcinog 45 (2006) 613-626
23. Goodman M.T., Correa C.N., Tung K.H., Roffers S.D., Cheng Wu X., Young Jr. J.L., et al. Stage at diagnosis of ovarian cancer in the United States, 1992-1997. Cancer 97 (2003) 2648-2659
24. Goodman M.T., and Howe H.L. Descriptive epidemiology of ovarian cancer in the United States, 1992-1997. Cancer 97 (2003) 2615-2630
25. Goodman M.T., Howe H.L., Tung K.H., Hotes J., Miller B.A., Coughlin S.S., et al. Incidence of ovarian cancer by race and ethnicity in the United States, 1992-1997. Cancer 97 (2003) 2676-2685
26. Pecorelli S., Favalli G., Zigliani L., and Odicino F. Cancer in women. Int J Gynaecol Obstet 82 (2003) 369-379
27. Rose N.R. Avian models of autoimmune disease: lessons from the birds. Poult Sci 73 (1994) 984-990
28. Sundick R.S., Bagchi N., and Brown T.R. The obese strain chicken as a model for human Hashimoto's thyroiditis. Exp Clin Endocrinol Diabetes 104 Suppl 3 (1996) 4-6
29. Vanderhyden B.C., Shaw T.J., and Ethier J.F. Animal models of ovarian cancer. Reprod Biol Endocrinol 1 (2003) 67
30. Fredrickson T.N. Ovarian tumors of the hen. Environ Health Perspect 73 (1987) 35-51
31. Lewis P.D., and Long S.E. Incidence of non-laying in domestic hens. Br Poult Sci 33 (1992) 289-295
32. Holschneider C.H., and Berek J.S. Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 19 (2000) 3-10
33. Tung K.H., Goodman M.T., Wu A.H., McDuffie K., Wilkens L.R., Kolonel L.N., et al. Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. Am J Epidemiol 158 (2003) 629-638
34. Runnebaum I.B., and Stickeler E. Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin Oncol 127 (2001) 73-79
35. Cramer D.W., Hutchison G.B., Welch W.R., Scully R.E., and Ryan K.J. Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J Natl Cancer Inst 71 (1983) 711-716
36. Barnes M.N., Berry W.D., Straughn J.M., Kirby T.O., Leath C.A., Huh W.K., et al. A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis. Gynecol Oncol 87 (2002) 57-63
37. Chen V.W., Ruiz B., Killeen J.L., Cote T.R., Wu X.C., and Correa C.N. Pathology and classification of ovarian tumors. Cancer 97 (2003) 2631-2642
38. Damjanov I. Ovarian tumours in laboratory and domestic animals. Curr Top Pathol 78 (1989) 1-10
39. Giles J.R., Olson L.M., and Johnson P.A. Characterization of ovarian surface epithelial cells from the hen: a unique model for ovarian cancer. Exp Biol Med (Maywood) 231 (2006) 1718-1725
40. Giles J.R., Shivaprasad H.L., and Johnson P.A. Ovarian tumor expression of an oviductal protein in the hen: a model for human serous ovarian adenocarcinoma. Gynecol Oncol 95 (2004) 530-533
41. Barua A., Abramowicz J., Bahr J., Bitterman P., Dirks A., Holub K., et al. Detection of ovarian tumors in chicken by ultrasonography - a step towards early diagnosis in humans?. J Ultrasound Med 26 (2007) 909-919
42. Rodriguez-Burford C., Barnes M.N., Berry W., Partridge E.E., and Grizzle W.E. Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecol Oncol 81 (2001) 373-379
43. Jackson E., Anderson K., Ashwell C., Petitte J., and Mozdziak P.E. CA125 expression in spontaneous ovarian adenocarcinomas from laying hens. Gynecol Oncol 104 1 (2006) 192-198
44. Barua A., Bradaric M., Edassary S., Rotmensch J., Bitterman P., Hales D., et al. Anti-tumor antibodies and ovarian cancer in women and hens. Special American Association for Cancer Research Conference, Molecular Diagnostics in Cancer Therapeutic Development: Maximizing Opportunities for Individualized Treatment (2006), Scholar-in-Training Award, Chicago, IL
45. Barua A, Edassery S, Bitterman P, Bahr J, Hales D, Luborsky J. Anti-tumor antibodies in serum of chickens with ovarian cancer. submitted for publication.
46. Urick M.E., and Johnson P.A. Cyclooxygenase 1 and 2 mRNA and protein expression in the Gallus domesticus model of ovarian cancer. Gynecol Oncol 103 (2006) 673-678